# Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients

> **NCT02728739** · NA · COMPLETED · sponsor: **Metanoic Health Ltd.** · enrollment: 500 (actual)

## Conditions studied

- Acute Heart Failure
- Mitral Regurgitation

## Interventions

- **PROCEDURE:** Transthoracic Echocardiogram (TTE) Assesment

## Key facts

- **NCT ID:** NCT02728739
- **Lead sponsor:** Metanoic Health Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-06
- **Primary completion:** 2017-12-29
- **Final completion:** 2018-02
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2018-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02728739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02728739, "Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02728739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*